CoChat

The biopharmaceutical aspects of nasal mucoadhesive drug delivery

Ugwoke, Michael Ikechukwu, Verbeke, Norbert, Kinget, Renaat · 2001 · Journal of Pharmacy and Pharmacology

The DOI matches its Crossref record; 125 of the 131 references it cites were found in a registry or an index.

Abstract

Nasal drug administration has frequently been proposed as the most feasible alternative to parenteral injections. This is due to the high permeability of the nasal epithelium, allowing a higher molecular mass cut-off at approximately 1000 Da, and the rapid drug absorption rate with plasma drug profiles sometimes almost identical to those from intravenous injections. Despite the potential of nasal drug delivery, it has a number of limitations. In this review, the anatomy and physiology of the nasal cavity, as well as ciliary beating and mucociliary clearance as they relate to nasal drug absorption, are introduced. The rationale for nasal drug delivery and its limitations, some factors that influence nasal drug absorption, and the experimental models used in nasal drug delivery research are also reviewed. Nasal mucoadhesion as a promising method of nasal absorption enhancement is discussed, and factors that influence mucoadhesion, as well as safety of nasal mucoadhesive drug delivery systems are reviewed in detail. Nasal drug administration is presently mostly used for local therapies within the nasal cavity. Anti-allergic drugs and nasal decongestants are the most common examples. However, nasal drug administration for systemic effects has been practised since ancient times. Nasally-administered psychotropic drugs by native Americans, the use of tobacco snuffs, and nasal administration of illicit drugs such as cocaine are all well known (Illum & Davis 1992). Nowadays, the nasal cavity is being actively explored for systemic administration of other therapeutic agents, particularly peptides and proteins (Illum 1992; Edman & Bjork 1992), as well as for immunization purposes (Lemoine et al 1998). To better understand the basis for nasal drug absorption and factors that can influence it, a brief review of the anatomy and physiology of the nose is appropriate.

Overview

Integrity signals

Registry

Crossref · 10.1211/0022357011775145

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 125 references

Research works printed but not linked: 19

  1. Arnaud, 1993, Enhancers of gastrointestinal tract, 15
  2. Baroody, 1999, Anatomy and physiology, 1
  3. Burkitt, 1993, Wheater's Functional Histology
  4. Chien, 1995, Biopharmaceutics basis for transmucosal delivery. S.T.P, Pharma. Sci., 5, 257
  5. Illum, 1992, Nasal delivery of peptides, factors affecting nasal absorption, 71
  6. Illum, 1992, Microspheres for nasal administration, 125
  7. Kamath, 1994, Mucosal adhesive preparations, 133
  8. Lindberg, 1997, Mucociliary transport, 155
  9. Longer, 1986, Fundamental aspects of bioadhesion, Pharm. Int., 5, 114
  10. Petri, 1985, Development of metered-dose nebulizer for intranasal peptide administration, 161
  11. Proctor, 1977, The upper airways I. Nasal physiology and defence of the lungs, Am. Rev. Respir. Dis., 115, 97
  12. Rice, 1978, The microbiology of parasinus infections: diagnosis and treatment, CRC Crit. Rev. Clin. Lab. Sci., 9, 105
  13. Ridley, 1992, Drug delivery to the buccal and nasal cavities, anatomical and physiological considerations, 29
  14. Sanders, 1997, The deposition of solution-based and suspension-based aerosols from metered dose inhalers in healthy subjects and asthmatic patients, S. T. P. Pharma Sci., 7, 300
  15. Satir, 1985, Switching mechanisms in control of ciliary motility, Mod. Cell Biol., 4, 1
  16. Sciarra, 1986, Pharmaceutical aerosols, 589
  17. Sciarra, 1990, Aerosols, 1694
  18. Tobyn, 1996, Factors affecting in vitro gastric mucoadhesion II. Properties of polymer, Eur. J. Pharm. Biopharm., 42, 56
  19. Ugwoke, 1999, Development and Evaluation of Controlled Release Nasal Drug Delivery Systems of Apomorphine

Cited by

See all 355

Metadata

Authors
Ugwoke, M. I., Verbeke, N., & Kinget, R.
Affiliations
KU Leuven (BE)
Venue
Journal of Pharmacy and Pharmacology
Published
2001-01-01
Volume
53
Issue
1
Pages
3-21
ISSN
  • 0022-3573 (ISSN-L)
  • 2042-7158
OpenAlex
W1969948087
Cited by
355
References
131
Citations by year
2026: 15 · 2025: 17 · 2024: 17 · 2023: 19 · 2022: 18 · 2021: 9 · 2020: 18 · 2019: 11 · 2018: 19 · 2017: 9 · 2016: 14 · 2015: 13 · 2014: 13 · 2013: 15 · 2012: 17
FWCI
0.81
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Pharmacy and Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
  • Lirias (KU Leuven) (submittedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
  • Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
Keywords
intranasal drug delivery, mucoadhesion, nasal absorption, ciliary beating, mucociliary clearance, systemic drug administration, antiallergic drugs, nasal decongestants, protein and peptide delivery, intranasal immunization
MeSH terms
Administration, Intranasal, Animals, Binding Sites, Dogs, Humans, Mucous Membrane, Nasal Cavity, Permeability, Rabbits, Drug Delivery Systems, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The biopharmaceutical aspects of nasal mucoadhesive drug delivery. https://app.cochat.ai/papers/10.1211/0022357011775145
The paper
Ugwoke, M. I., Verbeke, N., & Kinget, R. (2001). The biopharmaceutical aspects of nasal mucoadhesive drug delivery. Journal of Pharmacy and Pharmacology. https://doi.org/10.1211/0022357011775145

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.